androstanols - CISMeF

Preferred Label : androstanols;

MeSH definition : Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups.;

MeSH synonym : hydroxyandrostanes;

MeSH annotation : do not confuse with ANDROSTENOLS;

Is substance : O;

Details

Origin ID

D000732;

UMLS CUI

C0002856;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- 5.alpha.-androstan-3.beta.-ol [Substance BNPC]
Record concept(s)
- androstanols [MeSH concept]
Related MeSH Supplementary Concept(s)
- (17,17-di-n-propyl-17a-aza-D-homo-5alpha-androstan-3beta-ol) [MeSH Supplementary Concept]
- (4'-methyl-1'-piperazinyl)-dihydroxyl-androstane [MeSH Supplementary Concept]
- 1,2-seco-A-bis(norandrostan-17-ol)acetate [MeSH Supplementary Concept]
- 1,3,5,6-tetrahydroxyandrostan-17-one [MeSH Supplementary Concept]
- 1,3-trimethylene-2',5-epoxyandrostane-3,17-diol 17-propionate [MeSH Supplementary Concept]
- 1-(3-hydroxyandrostan-17-yl)-2-propen-1-one [MeSH Supplementary Concept]
- 11,17-dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one [MeSH Supplementary Concept]
- 16,17-epoxyandrostan-3-ol [MeSH Supplementary Concept]
- 16-hydroxymethyl-5-androstane-3,17-diol [MeSH Supplementary Concept]
- 17 beta-(3-furyl)-5 beta,14 beta-androstane-3 beta,14 beta-diol [MeSH Supplementary Concept]
- 17-(((4-aminobutoxy)imino)methyl)-5-androstane-3,14-diol [MeSH Supplementary Concept]
- 17-(1-hydroxy-2,3-butadienyl)androstan-3-ol [MeSH Supplementary Concept]
- 17-(2-((2-aminoethoxy)imino)ethyl)androstane-3,14-diol [MeSH Supplementary Concept]
- 17-(3'-thiophenyl)androstane-3,14-diol 3-glucopyranoside [MeSH Supplementary Concept]
- 17-(3-((2-dimethylaminoethoxy)imino)propyl)-5-androstane-3,14-diol [MeSH Supplementary Concept]
- 17-(3-pyridyl)-16,17-epoxy-5alpha-androst-3-ol [MeSH Supplementary Concept]
- 17-acetamido-5-androstan-3-ol-4-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 17-ethyl-17-hydroxyandrostane [MeSH Supplementary Concept]
- 17-ethynylandrostane-3,17-diol [MeSH Supplementary Concept]
- 17-hydroxy-17-methyl-2,3-secoandrostane-2,3-dioic acid [MeSH Supplementary Concept]
- 17-hydroxy-2,3-cyclopropanoandrostane [MeSH Supplementary Concept]
- 17-methyl-17a-chloro-D-homoandrostan-3-ol [MeSH Supplementary Concept]
- 17-methylepithiostanol [MeSH Supplementary Concept]
- 2-(2-(3-hydroxy-12-(2-methyl-1-oxobutoxy)-5-androstan-17-yl)ethyl)tetrahydro-4-hydroxy-2H-pyran-6-one [MeSH Supplementary Concept]
- 3 beta-acetoxy-5,6 beta-dichloromethylene-5 beta-androstan-17-one [MeSH Supplementary Concept]
- 3,3-difluoroandrostane-17-ol acetate [MeSH Supplementary Concept]
- 3-((N-adamantylmethyl-N-butanoyl)aminomethyl)-3-hydroxyandrostan-17-one [MeSH Supplementary Concept]
- 3-O-(carboxymethyl)oximinoandrostan-17-ol [MeSH Supplementary Concept]
- 3-acetoxy-7,15-oxido-16-oxaandrostan-17-one [MeSH Supplementary Concept]
- 3-chloro-17alpha-methyl-5alpha-androstan-17beta-ol [MeSH Supplementary Concept]
- 3-hemisuccinamidoandrostan-17-ol [MeSH Supplementary Concept]
- 3-hydroxy-15-oxaandrostan-17-one [MeSH Supplementary Concept]
- 3-hydroxy-17-(1H-1,2,3-triazol-1-yl)androsta-5,16-diene [MeSH Supplementary Concept]
- 3-hydroxy-5-androstane-17-carbonitrile [MeSH Supplementary Concept]
- 3-hydroxyandrostane-17-carbonitrile [MeSH Supplementary Concept]
- 3-hydroxyetianic acid [MeSH Supplementary Concept]
- 3-keto-5,10-epoxy-nor-19-methylandrostane-17-acetate [MeSH Supplementary Concept]
- 4,5-epoxy-17-hydroxy-2-methylsulfonyl-3-androstanone [MeSH Supplementary Concept]
- 5-bromo-3,6-dihydroxyandrostan-17-one-3-acetate [MeSH Supplementary Concept]
- 5-dihydrorubrosterone [MeSH Supplementary Concept]
- 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine [MeSH Supplementary Concept]
- 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine 5'-monophosphate [MeSH Supplementary Concept]
- 6-hydroxy-3,5-cycloandrostan-17-one [MeSH Supplementary Concept]
- BOMT [MeSH Supplementary Concept]
- CCI 22277 [MeSH Supplementary Concept]
- N-cyano-2-aza-A-norandrostan-17-ol acetate [MeSH Supplementary Concept]
- ORG 9943 [MeSH Supplementary Concept]
- ORG 9991 [MeSH Supplementary Concept]
- RU 26988 [MeSH Supplementary Concept]
- amafolone [MeSH Supplementary Concept]
- androsol acetate [MeSH Supplementary Concept]
- androst-3,5,6-triol [MeSH Supplementary Concept]
- androstan-17-ol [MeSH Supplementary Concept]
- androstan-3-ol [MeSH Supplementary Concept]
- dromostanolone [MeSH Supplementary Concept]
- dromostanolone propionate [MeSH Supplementary Concept]
- epitiostanol [MeSH Supplementary Concept]
- epitiostanol sulfoxide [MeSH Supplementary Concept]
- furazabol [MeSH Supplementary Concept]
- mebolazine [MeSH Supplementary Concept]
- mepitiostane [MeSH Supplementary Concept]
- nisterime acetate [MeSH Supplementary Concept]
- org NA13 [MeSH Supplementary Concept]
- proloteston [MeSH Supplementary Concept]
- rostafuroxin [MeSH Supplementary Concept]
- rubrosterone [MeSH Supplementary Concept]
- samanine [MeSH Supplementary Concept]
- spiro-3-oxiranylandrostan-17-ol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients